Post categorized under: Cannabis
With the Cannabis industry increasingly competitive for labs, growers and processors, new innovation and improved practices can be the difference in delivering ROI and outlasting competitors. PathogenDx delivers a unique Microarray technology that dramatically reduces testing turnaround time, adds flexibility to how and what can be tested for, and increases efficiencies for a cleaner Cannabis future. Here are the issues Cannabis faces now, with insights to help us all compete and win.
- Cannabis Regulatory Compliance Is Well Worth The Cost
While in many ways it still feels like an entirely new frontier, widespread legalization in the United States began more than a full decade ago. In the time since, it has evolved into one of the fastest growing and most robust industries in the United States, generating billions of dollars in sales each year. In the states where it’s legal, it is also one of the most heavily regulated industries.
- What’s In New York’s Illicit Cannabis? Germs, Toxins and Metals
Some Cannabis products sold at unlicensed storefronts in New York are not only illegal, but also contaminated with harmful bacteria, heavy metals and toxic pesticides, according to an industry report released last week. A medical Cannabis trade group found contaminants such as E. coli and salmonella in some products purchased at these unlicensed dispensaries.
- Many California Cannabis Companies Inflate THC Numbers: Here’s How They Can Stop Them
California’s state Cannabis & Hemp regulations and consumer habits emphasize the importance of THC content of Cannabis products. This has encouraged those with bad intentions to manipulate lab results and sell their products at a higher price.
- Has the CBD Regulatory Landscape Changed?
The regulation of CBD in the United States can be described as makeshift, and that is being generous. On a federal level, Cannabis in all shapes and forms is a Schedule I controlled substance, but no federal agency has taken charge of regulating CBD products, leaving decisions up to the individual states.
- Florida Marijuana Testing Labs Under Fire as Industry Tackles Potency Problem
The issues of inflated THC potency results and lab shopping are plaguing states with large Cannabis industries. The situation has created a public mistrust of marijuana testing-labs as well as a trend among marijuana businesses to shop for labs that will give them favorable test results.
- The Cannabis Regulation Crossroads in Massachusetts
The first five years of recreational Cannabis regulation in Massachusetts revealed a handful of problems. The industry is not diverse and equitable, and cities and towns have unethically taken advantage of the regulatory leverage they can hold over marijuana businesses. The state expects to reopen its regulations for additions, subtractions and revisions sometime later this year, as the industry has many wrongs to right.
- Minnesota Legalizes Adult-Use Recreational Cannabis
The new law modifies Minnesota’s list of controlled substances to exclude “industrial hemp” products that contain no more than 0.3% of any form of THC. That change brought Minnesota law in line with federal law. However, the law also allows Minnesota businesses to sell edible and drinkable products containing no more than five milligrams of THC per serving and no more than 50 milligrams of THC per package to people ages 21 and older.
- New York Regulators Approve Adult-Use Cannabis Testing Regulations
The approved interim regulations for New York’s Cannabis testing labs will ensure adult-use Cannabis products are not contaminated with pesticides, heavy metals or other adulterations. The rules will allow medical Cannabis testing labs to expand their operations to serve the adult-use market as well.
- South Dakota Adds New Standards for Testing Medical Cannabis
The effect of the rules will be to add regulations on testing of medical cannabis, including creation of batches and collection of samples. Under the rules, Cannabis testing labs must also update the inventory tracking system daily with all samples collected and the results of all tests performed.
- Why Utah Isn’t Testing Medical Marijuana
For over a year, Utah has not been pathogen testing medical marijuana for the typically tested for pathogenic bacteria. Last April, the Utah Department of Agriculture and Food suspended the requirement for pathogen-specific testing.
The short answer: due to an equipment shortage, the state said it suspended Cannabis lab testing for E.coli, salmonella and several kinds of molds that cause illness, especially among the immunocompromised.